Clinical studies with silymarin: fibrosis progression is the end point
- PMID: 11172360
- DOI: 10.1002/hep.510330230
Clinical studies with silymarin: fibrosis progression is the end point
Comment on
-
Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats.Hepatology. 1997 Sep;26(3):643-9. doi: 10.1002/hep.510260316. Hepatology. 1997. PMID: 9303494
-
Silymarin: What is in the name...? An appeal for a change of editorial policy.Hepatology. 2000 Aug;32(2):442-4. doi: 10.1053/jhep.2000.9770. Hepatology. 2000. PMID: 10960282 No abstract available.
-
Silymarin in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid.Hepatology. 2000 Nov;32(5):897-900. doi: 10.1053/jhep.2000.18663. Hepatology. 2000. PMID: 11050036 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources